false
Catalog
Pulmonary Hypertension: Expert Didactics and Discu ...
When Pulmonary Hypertension Complicates Lung Disea ...
When Pulmonary Hypertension Complicates Lung Disease SOOD
Back to course
Pdf Summary
Dr. Namita Sood presents a comprehensive overview of diagnosing and treating pulmonary hypertension (PH) complicating lung disease. PH is commonly seen in patients with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), and related conditions, and its presence can significantly worsen patient prognosis. The current diagnostic criteria for PH include a mean pulmonary arterial pressure (mPAP) of 20 mmHg with elevated pulmonary vascular resistance (PVR). Severe PH, however, is less frequently observed, with only a small percentage of COPD and ILD patients affected.<br /><br />The session outlines diagnostic approaches and highlights the complexities of diagnosing PH in the context of lung disease. Right heart catheterization is emphasized as crucial for confirming suspected PH. Therapies for this condition vary, with a focus on optimizing treatments for underlying lung diseases, potential supplemental oxygen, and considering coexistent conditions like left heart dysfunction or sleep apnea.<br /><br />Dr. Sood also discusses treatment approaches, pointing out inhaled Treprostinil as a specific therapy approved for PH associated with ILD. The results of multiple drug trials are reviewed, showing the limited benefits of vasodilators in Group III PH, which covers PH secondary to lung diseases. Research indicates that while some medications can improve hemodynamic parameters, clinical benefits remain uncertain.<br /><br />Long-term management strategies incorporate pulmonary rehabilitation and consider lung transplantation for advanced cases. Future treatment directions will likely involve deeper phenotyping of patients to better target therapies and assess clinical and quality-of-life outcomes. Ultimately, the need for new therapeutic approaches that address the underlying processes of PH, such as proliferation, inflammation, and fibrosis, are highlighted as essential.<br /><br />For further understanding, the document encourages attending expert discussions and refers to specific clinical references and ongoing trials to treat or study PH in conjunction with lung diseases.
Keywords
pulmonary hypertension
PH
lung disease
COPD
Chronic Obstructive Pulmonary Disease
interstitial lung disease
right heart catheterization
inhaled Treprostinil
vasodilators
pulmonary rehabilitation
lung transplantation
phenotyping
COPD
Chronic Obstructive Pulmonary Disease
Pulmonary Hypertension
PH
©
|
American College of Chest Physicians
®
×
Please select your language
1
English